Patents by Inventor Sung Eun Choe

Sung Eun Choe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240148697
    Abstract: The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2 and R3 are as defined herein.
    Type: Application
    Filed: June 9, 2023
    Publication date: May 9, 2024
    Inventors: Danielle Ulanet, Sung Eun Choe
  • Patent number: 11717512
    Abstract: The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2 and R3 are as defined herein.
    Type: Grant
    Filed: February 19, 2019
    Date of Patent: August 8, 2023
    Assignee: Servier Pharmaceuticals LLC
    Inventors: Danielle Ulanet, Sung Eun Choe
  • Publication number: 20220000878
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Application
    Filed: May 12, 2021
    Publication date: January 6, 2022
    Inventors: Bin Wu, Sung Eun Choe
  • Publication number: 20210113531
    Abstract: The present invention provides methods for treating cancer in a subject with a trisubstituted benzotriazole derivative with the formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables R1, R2 and R3 are as defined herein.
    Type: Application
    Filed: February 19, 2019
    Publication date: April 22, 2021
    Inventors: Danielle Ulanet, Sung Eun Choe
  • Publication number: 20200268726
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Application
    Filed: December 2, 2016
    Publication date: August 27, 2020
    Inventors: Bin Wu, Sung Eun Choe
  • Publication number: 20200261434
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Application
    Filed: May 7, 2020
    Publication date: August 20, 2020
    Inventors: Sung Eun Choe, Bin Wu, Michael Amatangelo, Xiaolan Hu, Anjan Thakurta
  • Publication number: 20190046512
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Application
    Filed: December 2, 2016
    Publication date: February 14, 2019
    Applicants: Agios Pharmaceuticals, Inc., Celgene Corporation, Celgene Corporation
    Inventors: Michael Amatangelo, Xiaolan Hu, Anjan Thakurta, Sung Eun Choe, Bin Wu
  • Patent number: 10188656
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: January 29, 2019
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Bin Wu, Sung Eun Choe
  • Publication number: 20180371551
    Abstract: The present invention provides diagnostic and prognostic methods for predicting the effectiveness of treatment of a cancer patient with a MAT2A inhibitor. Methods are provided for predicting the sensitivity of tumor cell growth to inhibition by a MAT2A inhibitor, comprising assessing whether the tumor cell is absent an MTAP gene whereby cells that are MTAP null are sensitive to inhibition by MAT2A inhibitors.
    Type: Application
    Filed: December 2, 2016
    Publication date: December 27, 2018
    Inventors: Katya Marjon, Sung Eun Choe
  • Patent number: 10137130
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: November 27, 2018
    Assignees: Celgene Corporation, Agios Pharmaceuticals, Inc.
    Inventors: Michael Amatangelo, Xiaolan Hu, Anjan Thakurta, Sung Eun Choe, Bin Wu
  • Patent number: 10101331
    Abstract: Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: October 16, 2018
    Assignee: Agios Pharmaceuticals, Inc.
    Inventors: Jonathan Hurov, Sung Eun Choe, Danielle Ulanet
  • Publication number: 20170299593
    Abstract: Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Application
    Filed: February 28, 2017
    Publication date: October 19, 2017
    Inventors: Jonathan Hurov, Sung Eun Choe, Danielle Ulanet
  • Publication number: 20170246174
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Application
    Filed: December 2, 2016
    Publication date: August 31, 2017
    Inventors: Michael Amatangelo, Xiaolan Hu, Anjan Thakurta, Sung Eun Choe, Bin Wu
  • Publication number: 20170157132
    Abstract: Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.
    Type: Application
    Filed: December 2, 2016
    Publication date: June 8, 2017
    Inventors: Bin Wu, Sung Eun Choe
  • Patent number: 9618514
    Abstract: Methods for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: April 11, 2017
    Assignee: AGIOS PHARMACEUTICALS, INC
    Inventors: Sung Eun Choe, Jonathan Hurov, Danielle Ulanet
  • Publication number: 20150276744
    Abstract: Methods and kits for the selection, evaluation, and/or treatment of a patient having cancer with an inhibitor of a glutamine-utilizing enzyme or a glutamine-depleting agent, by evaluating E-cadherin or vimentin expression are disclosed.
    Type: Application
    Filed: September 16, 2013
    Publication date: October 1, 2015
    Applicant: AGIOS PHARMACEUTICALS, INC
    Inventors: Sung Eun Choe, Jonathan Hurov, Danielle Ulanet